CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 273 enrolled
Drug / intervention
Provision of audit and feedback via email and paper +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05761873
NCT05761873N/ACompleted

Comparing Paper Letters in Addition to Emailed Audit and Feedback in Refining Asthma Treatment to Improve Clinical and Environmental Results in Primary Care

University of Leeds·interventional·Posted Mar 9, 2023·Updated Jan 22, 2026

In Brief

A clinical study evaluating Provision of audit and feedback via email and paper and Provision of audit and feedback via paper only for Asthma. Completed, enrolled 273 participants across 1 site.

Detailed Summary

Public Health England have estimated that 36,000 excess deaths occur each year due to UK air pollution. Respiratory inhalers produce 3% of NHS greenhouse gas production. The two main inhaler device categories are pressurised Metered Dose Inhalers (pMDIs) and Dry Powder Inhalers (DPIs). The chemical propellant in pMDIs is the majority cause of inhaler carbon footprint, with pMDIs having an 18 times higher carbon footprint than DPIs. The rates of asthma in the UK population are amongst the highest worldwide and its mortality rate remains amongst the worst in Europe. A pre-existing Audit and Feedback (A\&F) quality improvement project (QIP) is being undertaken by NHS West Yorkshire Integrated Care Board (ICB) with the aim of improving asthma outcomes and reducing the environmental impact of inhalers in primary care. The A\&F being utilised here has been validated locally in two peer reviewed studies and is now standard practice in the region. There is convincing evidence that A\&F has a positive effect on enacting behaviour change, especially where behaviour change is related to prescribing with low baseline compliance with guidelines. However, the evidence base is poor on which design features of A\&F produce enhanced results. There is supporting evidence from local studies suggesting that posted paper A\&F may be more effective at producing behaviour change than emailed copies of A\&F alone. This study seeks to randomise the primary care practices within the pre-arranged QIP, to receive either a paper and emailed A\&F report bimonthly for the duration of the study period, or to receive an emailed A\&F report alone. The primary outcome of the study would be a comparison of the number of 'low-global warming potential' inhalers prescribed as a percentage of the total prescribed inhalers from each intervention group.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
202420252026
First PostedMar 9, 2023
Enrollment StartApr 24, 2023
Primary CompletionMay 17, 2024
Study CompletionApr 17, 2025
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 3.3 years ago

Interventions

Provision of audit and feedback via email and paperother

Provision of A\&F reports by paper via the post (new intervention being trialled) and email (standard practice) to allocated practices depending on randomisation status.

Provision of audit and feedback via paper onlyother

Provision of A\&F reports by email (standard practice in the region) to allocated practices depending on randomisation status.